AAA
WVE icon

Affinity Asset Advisors’s Wave Life Sciences WVE Stock Holding History

Affinity Asset Advisors’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,401,727
Closed -$10.2M – 128
2026
Q1 		$10.2M Sell
1,401,727
-1,298,273
-48% -$16.9M 0.52% 48
2025
Q4 		$45.9M Buy
2,700,000
+600,000
+29% +$6.1M 2.62% 11
2025
Q3 		$15.4M Buy
2,100,000
+99,692
+5% +$807K 1.34% 23
2025
Q2 		$13M Buy
2,000,308
+175,308
+10% +$1.16M 1.78% 17
2025
Q1 		$14.7M Buy
1,825,000
+325,000
+22% +$3.55M 1.41% 19
2024
Q4 		$18.6M Buy
1,500,000
+100,000
+7% +$1.33M 2.49% 12
2024
Q3 		$11.5M Buy
1,400,000
+1,025,000
+273% +$6.13M 1.57% 23
2024
Q2 		$1.87M Buy
375,000
+88,415
+31% +$504K 0.22% 66
2024
Q1 		$1.77M Buy
+286,585
New +$1.44M 0.22% 75

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Affinity Asset Advisors's WVE Position: Q2 2026 in Review

Affinity Asset Advisors sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 1,401,727 shares — an estimated $10.2M sold.

Affinity Asset Advisors first reported a position in WVE in Q1 2024 and held it in 9 quarters. The position peaked at $45.9M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Affinity Asset Advisors reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Affinity Asset Advisors sold 1,401,727 Wave Life Sciences shares in Q2 2026, an estimated $10.2M.
  • Affinity Asset Advisors first reported a position in Wave Life Sciences in Q1 2024 and held it in 9 quarters.
  • Affinity Asset Advisors's Wave Life Sciences position peaked at $45.9M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Affinity Asset Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.